OBJECTIVE	The aim of this study was to evaluate the efficacy and safety of intralesional bevacizumab , a monoclonal antibody against vascular endothelial growth factor , in patients with human immunodeficiency virus ( HIV ) - associated Kaposi 's sarcoma of the upper airway receiving antiretroviral therapy .\